Report Highlights
- Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players
- Neurology set to be the fastest-growing device area with a CAGR of 9.1% between 2017 and 2024; diagnostic imaging and orthopedics will be the slowest, with annual growth of just 3.7% between these years
- Medtronic remains the leading medtech company in 2017 with sales of $30bn and will remain at the top in 2024 with sales forecast to reach $38.9bn
The EvaluateMedTech World Preview 2018 highlights trends in medtech and includes consensus sales forecasts by device area to 2024, the top 20 companies in 2024, R&D spend current and future and FDA approvals.
